Bill > HB2871

This bill appropriates $5 million from the Arizona state general fund in fiscal year 2025-2026 to the Department of Health Services to award a grant for a certified clinical research study on ibogaine (a psychoactive substance) for treating neurological diseases, specifically traumatic brain injury and post-traumatic stress disorder. The grant can only be awarded to an entity that meets four specific criteria: (1) having a proven history of research and treatment of neurological diseases, (2) possessing a neurosurgery program with advanced clinical and research facilities staffed by experts in complex neurological conditions, (3) demonstrating the ability to conduct pioneering research and innovation in neurological diagnosis and treatment, and (4) showing a commitment to match the state's funding with at least $5 million from non-state sources. Additionally, the bill provides an exemption from standard appropriations lapsing rules, meaning the funds will not automatically expire if unused within a typical timeframe. This represents a significant investment in exploring potential new treatments for challenging neurological conditions using ibogaine, which is currently a relatively unexplored therapeutic option.